Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0.385. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Allergy and Infectious Diseases
Grant: U19 AI142785, U19 AI109711
NIAID NIH HHS
Grant: U19 AI142785
NIAID NIH HHS
Grant: U19 AI109711
National Institutes of Health
Grant: 5U19AI109711-04
Advancement of Treatments for Ebola and Marburg Virus Infections
National Institutes of Health
Grant: 1U19AI142785-01
Advancement of Vaccines and Treatments for Ebola and Marburg Virus Infections
FWCI
0.96
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals